Cartesian Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 2.42 M | $43.40 M | -15.03% | 1.56% |
BIOIMPACT CAPITAL LLC | 02/14/2025 | 721.14 K | $12.92 M | 14.57% | 0.46% |
BLACKROCK, INC. | 02/07/2025 | 659.40 K | $11.81 M | 55.72% | 0.43% |
SIREN, L.L.C. | 02/14/2025 | 572.24 K | $10.25 M | 0.00% | 0.37% |
VANGUARD GROUP INC | 02/11/2025 | 429.48 K | $7.69 M | 76.68% | 0.28% |
CITADEL ADVISORS LLC | 02/14/2025 | 315.00 K | $5.64 M | -16.17% | 0.20% |
JPMORGAN CHASE & CO | 02/12/2025 | 274.74 K | $4.92 M | -11.09% | 0.18% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 221.26 K | $3.96 M | 63.05% | 0.14% |
02/10/2025 | 173.57 K | $3.26 M | 0.00% | 0.11% | |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 125.00 K | $2.24 M | 65.71% | 0.08% |
NORTHERN TRUST CORP | 02/14/2025 | 95.03 K | $1.70 M | 50.57% | 0.06% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 72.10 K | $1.29 M | 197.81% | 0.05% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 52.17 K | $934.29 K | -0.05% | 0.03% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 27.53 K | $492.97 K | 142.81% | 0.02% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 26.80 K | $480.04 K | 40.71% | 0.02% |
FREESTONE CAPITAL HOLDINGS, LLC | 02/06/2025 | 25.92 K | $464.25 K | 0.00% | 0.02% |
MORGAN STANLEY | 02/14/2025 | 24.26 K | $434.53 K | 10.23% | 0.02% |
DELPHI FINANCIAL GROUP, INC. | 02/06/2025 | 22.03 K | $394.52 K | 0.00% | 0.01% |
ALPS ADVISORS INC | 02/13/2025 | 20.55 K | $368.05 K | 100.00% | 0.01% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 19.41 K | $347.58 K | 28.51% | 0.01% |
BARCLAYS PLC | 02/13/2025 | 19.10 K | $342.00 K | 64.49% | 0.01% |
UBS GROUP AG | 02/14/2025 | 17.58 K | $314.86 K | 229.28% | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 14.49 K | $259.53 K | -0.19% | 0.01% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 13.80 K | $247.16 K | 100.00% | 0.01% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 02/13/2025 | 12.00 K | $214.92 K | 0.00% | 0.01% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 11.81 K | $211.55 K | -8.51% | 0.01% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 11.69 K | $209.37 K | 54.43% | 0.01% |
SQUAREPOINT OPS LLC | 02/14/2025 | 10.65 K | $190.78 K | 2.49% | 0.01% |
RHUMBLINE ADVISERS | 01/30/2025 | 10.20 K | $182.69 K | 10.00% | 0.01% |
CITIGROUP INC | 02/12/2025 | 8.25 K | $147.78 K | 58.16% | 0.01% |
METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 6.67 K | $119.41 K | 100.00% | 0.00% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 5.79 K | $103.63 K | 44.76% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2025 | 5.46 K | $98.00 K | 85.91% | 0.00% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 5.39 K | $96.52 K | 100.00% | 0.00% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 5.12 K | $91.74 K | 32.56% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 4.85 K | $86.81 K | 112.68% | 0.00% |
JOHNSON FINANCIAL GROUP, INC. | 02/14/2025 | 4.62 K | $89.17 K | 0.00% | 0.00% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 4.56 K | $17.43 K | 22.80% | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 3.90 K | $70.00 K | -23.52% | 0.00% |
DEUTSCHE BANK AG\ | 02/14/2025 | 3.64 K | $65.16 K | 0.00% | 0.00% |
VIRTUS ETF ADVISERS LLC | 02/14/2025 | 3.53 K | $63.28 K | 100.00% | 0.00% |
HALL LAURIE J TRUSTEE | 01/16/2025 | 1.76 K | $32.00 K | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1.65 K | $29.46 K | -0.36% | 0.00% |
02/11/2025 | 1.45 K | $26.02 K | 100.00% | 0.00% | |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 1.15 K | $20.60 K | 43.57% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 02/13/2025 | 708 | $12.68 K | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 623 | $11.16 K | 9.88% | 0.00% |
02/19/2025 | 534 | $9.56 K | 100.00% | 0.00% | |
WR WEALTH PLANNERS, LLC | 02/05/2025 | 233 | $591 | 497.44% | 0.00% |
AMALGAMATED BANK | 02/04/2025 | 130 | $2.00 K | 0.00% | 0.00% |
Cartesian Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Cartesian Therapeutics, Inc.. The most heavily invested institutionals were:
Squarepoint Ops LLC: 0
BOOTHBAY FUND MANAGEMENT, LLC: 0
Farther Finance Advisors, LLC: 0
HALL LAURIE J TRUSTEE: 0
Johnson Financial Group, Inc.: 0
Virtus ETF Advisers LLC: 0
4.19% of Cartesian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 875.24 K shares in the last 24 months. This purchase volume represents approximately $9.03 M in transactions.